Research programme: heart failure therapeutics - Cytokinetics/Amgen
Alternative Names: Cardiac sacromere activators; CK 0689705; CK 1122534; CK 1213296; CK 1316719; CK 689705Latest Information Update: 28 Jan 2020
At a glance
- Originator Cytokinetics
- Developer Amgen; Cytokinetics
- Class Cardiovascular therapies; Heart failure therapies; Small molecules
- Mechanism of Action Cardiac myosin stimulants; Troponin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Heart failure